Drug Shortage Report for PEGLYTE POWDER

Last updated on 2021-11-25 History
Report ID 149215
Drug Identification Number 00777838
Brand name PEGLYTE POWDER
Common or Proper name PEGLYTE POWDER
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM BICARBONATE SODIUM SULFATE MACROGOL
Strength(s) 3.05G 5.85G 6.76G 22.96G 238.18G
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL ORAL
Packaging size 4X70G
ATC code A06AD
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-09
Estimated end date 2021-12-10
Actual end date 2021-11-24
Shortage status Resolved
Updated date 2021-11-25
Company comments
Health Canada comments
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-11-15 English Compare
v2 2021-11-15 French Compare
v3 2021-11-24 English Compare
v4 2021-11-24 French Compare
v5 2021-11-25 English Compare